Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom-Reference-Cited by-同舟云学术

Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom

Published:2024-04-19 Issue:sup2 Volume:27 Page:20-29
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Engelbrecht Kayla¹,Ovcinnikova Olga¹,Ntais Dionysios¹,Shoel Hayley²,Meiwald Anne²,Hughes Robert²,Weston Georgie²,Morais Edith³,Bencina Goran⁴

Affiliation:

1. Department of Health Economics, MSD (UK) Limited, London, UK

2. Department of Health Economics, Adelphi Values PROVE, Bollington, UK

3. MSD France, Puteaux, France

4. Center for Observational and Real-World Evidence, MSD Spain, Madrid

Funder

Merck Sharp & Dohme LLC

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2024.2368986

Reference38 articles.

1. Ferlay J Ervik M Lam F et al. Global Cancer Observatory: Cancer Today. Estimated number of new cases in 2022 United Kingdom both sexes all ages (excl. NMSC). Lyon France: International Agency for Research on Cancer; 2024. Accessed 24 February 2024. https://gco.iarc.who.int/today.

2. The cost of cancer in Europe 2018

3. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

4. National Cancer Institute. HPV and Cancer. Accessed. 30th October 2023. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer.

5. National Health Services (NHS). HPV vaccine. Updated 1 September 2023. ; 2023 Accessed Oct . https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vaccine/#:∼:text=All%20children%20aged%2012%20to born%20after%201%20September%202006.